Active Ingredient(s):Palonosetron FDA Approved: * July 25, 2003 Pharm Company: *HELSINN HLTHCARE Category:Cancer
Palonosetron, sold under the brand name Aloxi, is used for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is a 5-HT3 antagonist.
Palonosetron is administered intravenously, or as a single oral capsule. It has a longer duration of action than other 5-HT3 antagonists. The oral formulation was approved on Aug...
* May have multiple approval dates, manufacturers, or labelers.